Literature DB >> 16368885

Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3.

Carmit Levy1, Yu-Nee Lee, Hovav Nechushtan, Ora Schueler-Furman, Amir Sonnenblick, Shelley Hacohen, Ehud Razin.   

Abstract

Protein inhibitor of activated STAT3 (PIAS3) functions in vivo as a key molecule in suppressing the transcriptional activity of both microphthalmia transcription factor (MITF) and signal transducer and activator of transcription 3 (STAT3), 2 transcription factors that play a major role in the regulation of growth and function in mast cells and melanocytes. Previously, we have demonstrated binding of PIAS3 to MITF leading to the inhibition of MITF transcriptional activity. Following cellular activation, PIAS3 is released from MITF and binds to STAT3. Now we have localized a common binding motif in PIAS3 for MITF and STAT3. This motif (PIAS82-132), which contains 50 amino acids, is sufficient for the inhibition of both MITF and STAT3. Three-dimensional protein modeling demonstrated that this motif contains 2 alpha helices. Disruption of one of the helices led to the loss of PIAS3 inhibitory activity. In addition to contributing to our understanding of the mechanisms of PIAS3 activity, these results could pave the way toward the formulation of an antioncogenic agent for the inhibition of both STAT3 and MITF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368885     DOI: 10.1182/blood-2005-08-3325

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.

Authors:  Cheng Quan; Yun-Qing Ren; Lei-Hong Xiang; Liang-Dan Sun; Ai-E Xu; Xing-Hua Gao; Hong-Duo Chen; Xiong-Ming Pu; Ri-Na Wu; Chao-Zhao Liang; Jia-Bin Li; Tian-Wen Gao; Jian-Zhong Zhang; Xiu-Li Wang; Jun Wang; Rong-Ya Yang; Ling Liang; Jian-Bin Yu; Xian-Bo Zuo; Sheng-Quan Zhang; Shu-Mei Zhang; Gang Chen; Xiao-Dong Zheng; Pan Li; Jun Zhu; Yong-Wei Li; Xiao-Dong Wei; Wei-Song Hong; Ying Ye; Yong Zhang; Wei-Su Wu; Hui Cheng; Pu-Ling Dong; Da-Yan Hu; Yang Li; Min Li; Xin Zhang; Hua-Yang Tang; Xian-Fa Tang; Sheng-Xin Xu; Su-Min He; Yong-Mei Lv; Min Shen; Hong-Quan Jiang; Ying Wang; Kai Li; Xiao-Jing Kang; Yu-Qin Liu; Li Sun; Zhi-Fang Liu; Shao-Qiong Xie; Cheng-Yao Zhu; Qiang Xu; Jin-Ping Gao; Wen-Long Hu; Cheng Ni; Ting-Meng Pan; Yun Li; Sha Yao; Cai-Feng He; Yang-Sheng Liu; Ze-Ying Yu; Xian-Yong Yin; Feng-Yu Zhang; Sen Yang; Youwen Zhou; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

2.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

3.  The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.

Authors:  Snehal Dabir; Amy Kluge; Afshin Dowlati
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

4.  Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype.

Authors:  Jun-ichi Kashiwakura; Wenbin Xiao; Jiro Kitaura; Yuko Kawakami; Mari Maeda-Yamamoto; Janet R Pfeiffer; Bridget S Wilson; Ulrich Blank; Toshiaki Kawakami
Journal:  J Leukoc Biol       Date:  2008-05-13       Impact factor: 4.962

5.  Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.

Authors:  Anja Duechting; Carsten Tschöpe; Heike Kaiser; Tobias Lamkemeyer; Nobuyuki Tanaka; Susanne Aberle; Florian Lang; Joseph Torresi; Reinhard Kandolf; C-Thomas Bock
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

6.  Towards a quantitative understanding of the MITF-PIAS3-STAT3 connection.

Authors:  Josef Thingnes; Timothy J Lavelle; Arne B Gjuvsland; Stig W Omholt; Eivind Hovig
Journal:  BMC Syst Biol       Date:  2012-02-08

Review 7.  MITF in melanoma: mechanisms behind its expression and activity.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  Cell Mol Life Sci       Date:  2014-11-30       Impact factor: 9.261

8.  A positive feedback loop between miR-181b and STAT3 that affects Warburg effect in colon cancer via regulating PIAS3 expression.

Authors:  Xiaolin Pan; Jin Feng; Zhenhua Zhu; Linhua Yao; Shijie Ma; Bo Hao; Guoxin Zhang
Journal:  J Cell Mol Med       Date:  2018-07-28       Impact factor: 5.310

Review 9.  Regulation of Natural Killer Cell Function by STAT3.

Authors:  Nicholas A Cacalano
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

Review 10.  New Insights into the Role of Sphingolipid Metabolism in Melanoma.

Authors:  Lorry Carrié; Mathieu Virazels; Carine Dufau; Anne Montfort; Thierry Levade; Bruno Ségui; Nathalie Andrieu-Abadie
Journal:  Cells       Date:  2020-08-26       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.